Symbols

VRCA

Verrica·NASDAQ

--(--)

VRCA Profile

Verrica Pharmaceuticals Inc.

A dermatology therapeutics company developing medications for skin diseases requiring medical interventions

Industry

Pharmaceutical

Established Date

07/03/2013

Listing Date

06/15/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.verrica.com

Security Type

Common stock

Office address

44 West Gay Street, Suite 400, West Chester, PA 19380

Business

Introduction

Verrica Pharmaceuticals Inc., was incorporated under the laws of the State of Delaware on July 3, 2013. The Company is a company that develops and commercializes clinically administered therapeutic drugs for skin diseases, including skin cancer. Its commercial product YCANTH has been approved for the treatment of molluscum contagiosum, and the R&D pipeline also includes drug candidates for warts vulgaris and basal cell carcinoma.